NLRP3 and diabetic kidney disease: Administration of N-acetylmannosamine (ManNAc) was found to protect podocytes from pyroptosis in mice with DKD by mitigating mitochondrial dysfunction and suppressing the ROS/NLRP3 signaling pathway [112].